Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Heeringa

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Arthritis Research & Therapy|March 5, 2011
In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitationsPeter Heeringa, Mark A Little
Current Opinion in Nephrology and Hypertension|May 1, 2002
Role of oxidized low-density lipoprotein in renal diseasePeter Heeringa, Jan W Cohen Tervaert
Molecular Immunology|November 25, 2015
Complement system activation in ANCA vasculitis: A translational success story?Cees G M Kallenberg, Peter Heeringa
Current Opinion in Rheumatology|November 18, 2011
Pathogenesis of ANCA-associated vasculitis: recent insights from animal modelsMirjan M van Timmeren, Peter Heeringa
Kidney International|December 29, 2012
Complement is crucial in the pathogenesis of ANCA-associated vasculitisCees G M Kallenberg, Peter Heeringa
APMIS. Supplementum|June 12, 2009
ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?Betty S van der Veen, Peter Heeringa
Methods in Molecular Biology (Clifton, N.J.)|November 17, 2010
Bone marrow transplantations to study gene function in hematopoietic cellsMenno P J de Winther, Peter Heeringa
Kidney International|February 19, 2002
A protective role for endothelial nitric oxide synthase in glomerulonephritisPeter Heeringa, Eric Steenbergen, Harry van Goor
Kidney International|June 24, 2018
The net effect of ANCA on neutrophil extracellular trap formationPeter Heeringa, Abraham Rutgers, Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Arthritis Research & Therapy|March 5, 2011
In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitationsPeter Heeringa, Mark A Little
Current Opinion in Nephrology and Hypertension|May 1, 2002
Role of oxidized low-density lipoprotein in renal diseasePeter Heeringa, Jan W Cohen Tervaert
Molecular Immunology|November 25, 2015
Complement system activation in ANCA vasculitis: A translational success story?Cees G M Kallenberg, Peter Heeringa
Current Opinion in Rheumatology|November 18, 2011
Pathogenesis of ANCA-associated vasculitis: recent insights from animal modelsMirjan M van Timmeren, Peter Heeringa
Kidney International|December 29, 2012
Complement is crucial in the pathogenesis of ANCA-associated vasculitisCees G M Kallenberg, Peter Heeringa
APMIS. Supplementum|June 12, 2009
ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?Betty S van der Veen, Peter Heeringa
Methods in Molecular Biology (Clifton, N.J.)|November 17, 2010
Bone marrow transplantations to study gene function in hematopoietic cellsMenno P J de Winther, Peter Heeringa
Kidney International|February 19, 2002
A protective role for endothelial nitric oxide synthase in glomerulonephritisPeter Heeringa, Eric Steenbergen, Harry van Goor
Kidney International|June 24, 2018
The net effect of ANCA on neutrophil extracellular trap formationPeter Heeringa, Abraham Rutgers, Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Pageof 18